Stock Yards Bank & Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

Stock Yards Bank & Trust’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$343K	Sell	691 -10	-1%	-$4.43K	0.01%	327
2026 Q1	$313K	Buy	701 +10	+1%	+$4.66K	0.01%	331
2025 Q4	$313K	Sell	691 -98	-12%	-$42.2K	0.01%	333
2025 Q3	$309K	Sell	789 -20	-2%	-$8.36K	0.01%	332
2025 Q2	$360K	Buy	809 +295	+57%	+$136K	0.01%	310
2025 Q1	$249K	Buy	514 +9	+2%	+$4.19K	0.01%	348
2024 Q4	$203K	Buy	+505	New	+$234K	0.01%	359
2023 Q3	–	Sell	-799	Closed	-$281K	–	404
2023 Q2	$281K	Sell	799 -87	-10%	-$29.3K	0.01%	338
2023 Q1	$279K	Hold	886	–	–	0.01%	348
2022 Q4	$256K	Buy	886 +5	+0.6%	+$1.52K	0.01%	368
2022 Q3	$255K	Hold	881	–	–	0.01%	360
2022 Q2	$248K	Buy	+881	New	+$236K	0.01%	376

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Stock Yards Bank & Trust's VRTX Position: Q2 2026 in Review

Stock Yards Bank & Trust reduced its Vertex Pharmaceuticals (VRTX) stake by 1.4% in Q2 2026, selling an estimated $4.43K and leaving 691 shares worth $343K. The position accounts for 0.01% of the portfolio, ranked #327.

Stock Yards Bank & Trust first reported a position in VRTX in Q2 2022 and has held it in 12 quarters since. The position peaked at $360K in Q2 2025. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Stock Yards Bank & Trust held 691 shares of Vertex Pharmaceuticals worth $343K as of Q2 2026.
Stock Yards Bank & Trust sold 10 Vertex Pharmaceuticals shares in Q2 2026, an estimated $4.43K.
Vertex Pharmaceuticals made up 0.01% of Stock Yards Bank & Trust's portfolio in Q2 2026, its #327 holding.
Stock Yards Bank & Trust first reported a position in Vertex Pharmaceuticals in Q2 2022 and has held it in 12 quarters since.
Stock Yards Bank & Trust's Vertex Pharmaceuticals position peaked at $360K in Q2 2025.
1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Stock Yards Bank & Trust's 13F filing for Q2 2026, filed 13 Aug 2026.